Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)
NCT06684184
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Myasthaenia Gravis
Interventions
DRUG:
Blinatumomab
Sponsor
Zhongming Qiu